Fintepla Uniunea Europeană - română - EMA (European Medicines Agency)

fintepla

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptice, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

FINTEPLA România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fintepla

millmount healthcare ltd - irlanda - fenfluraminum - sol. orala - 2,2mg/ml - antiepileptice alte antiepileptice

GLIMEPIRIDA ACCORD 1 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glimepirida accord 1 mg

accord healthcare limited - glimepiridum - compr. - 1mg - antidiabetice orale si parenterale , exclusiv insuline sulfonamide, derivati de uree

GLIMEPIRIDA ACCORD 2 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glimepirida accord 2 mg

accord healthcare limited - glimepiridum - compr. - 2mg - antidiabetice orale si parenterale , exclusiv insuline sulfonamide, derivati de uree

GLIMEPIRIDA ACCORD 3 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glimepirida accord 3 mg

accord healthcare limited - glimepiridum - compr. - 3mg - antidiabetice orale si parenterale , exclusiv insuline sulfonamide, derivati de uree

GLIMEPIRIDA ACCORD 4mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glimepirida accord 4mg

accord healthcare limited - glimepiridum - compr. - 4mg - antidiabetice orale si parenterale , exclusiv insuline sulfonamide, derivati de uree